|
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||
2008 BIOCOM Life Sciences John C. Reed is president and CEO of the Burnham Institute for Medical Research, a nonprofit biomedical research institute headquartered in San Diego. His research has focused primarily on cancer, but he has also made important contributions in the areas of AIDS, autoimmunity, stroke, and other diseases. Reed has been a pioneer in delineating the fundamental mechanisms that regulate programmed cell death, a process by which cells in the body commit suicide through activation of a genetically controlled program. His work has revealed how defects in programmed cell death contribute to diseases, resulting in novel strategies for therapeutic intervention. In 1989 Reed was appointed assistant professor, Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, and assistant director, Laboratory of Molecular Diagnosis at the Hospital of the University of Pennsylvania. Reed was recruited to the Burnham Institute in 1992. He founded and directed the institute's Program on Apoptosis and Cell Death Research until 2000. Reed served as the institute's scientific director from 1995 to 2001; he was appointed president and CEO in 2002. The author of more than 700 peer-reviewed articles, Reed is also the recipient of numerous awards and honors. He serves on the editorial boards of 10 scientific journals and on the board of directors of 7 companies or nonprofit organizations. Reed received a bachelor’s degree in biochemistry from the University of Virginia. He earned both an M.D. and a Ph.D. from the University of Pennsylvania School of Medicine, where he also received his clinical and postdoctoral training. About the BIOCOM Life Sciences Heritage Award |
Past recipients of the BIOCOM Life Sciences Heritage Award For information about the CHF Awards Program, contact: awards@chemheritage.org |
|||||||||||||||||||